Myoxinol is a complex of oligopeptides obtained by biotransformation of native proteins from the seeds of Okra plan. Okra trees grow mainly in South Asia and Africa. Their seeds are widely used in traditional medicine but also as a food source. Myoxinol is a plant-based Botox-like compounds which can have similar effects by Botox injection but without its associated risks. It has been clinically demonstrated that Myoxinol reduces muscle contraction thus reducing the likelihood of the formation of facial expression lines. This Botox-like activity is complemented by efficacy against biological aging, helping to preserve optimal skin elasticity.
Compared with white grapes, red grapes which has resveratrol are very rarely affected by grape moulds. Viniderm® is a grape juice extract from Languedoc-Roussillon, rich in polyphenois, enriched in a rare polyherol: the o-viniferin. This one is obtained by enzymatic bioconversation from resveratrol. This process is inspired by a reaction existing in the natural state, catalysed by a mushroom, Botrytis Cinerea. Its diversity in antioxidant polyphenols, allows this product to have an anti-aging preservative action by protecting the essential constituents of the skin such as the mitochondrial DNA, the stem cell niche, and the extra-cellular matrix. It has been demonstrated clinically, substantial reduction in visiable wrinkles are observed after using 3% Viniderm Essence for 56 days.
Wonderlight is formulated from extraction of the plant Humulus Lupulus (Hops). It has been clinically proven in decreasing hyperpigmentation situation accentuated by age and stress: lentigines, ephelides, postinflammatory spots and melasma. Wonderlight interacts with both keratinocytes and melanocytes by blocking gene transcription involved in the melanin synthesis. The inflammatory cytokine GM-CSF produced by keratinocytes is inhibited. Clinicaly studies have demonstrated that Wonderlight can markedly improve skin luminosity and reduce skin pigmentation after continuous use of 28 days, especially on type III / IV Asian skins.
Argireline, also known as Acetyl heyxapeptide-3, is a peptide patented by the Barcelona-based research laboratory Lipotec. ARGIRELINE® peptide solution is the first anti-wrinkle hexapeptide with a Botulinum Toxin-like mechanism of action. It has the effect of Botox but without the risk of direct injection. It reduces the depth of the wrinkles on the face caused by the contraction of muscles of facial expression, especially in the forehead and around the eyes. ARGIRELINE® is a safer, cheaper, and milder alternative to Botulinum Toxin, topically targeting the same wrinkle-formation mechanism in a very different way. Clinical studies have demonstrated that Argireline solution reduced the depth of wrinkles up to 17% after 15 days and 27% following 30 days of treatment.